Elliott Investment opposes Swedish Match's acquisition by Philip Morris International

Jul.11.2022
Elliott Investment opposes Swedish Match's acquisition by Philip Morris International
Elliott Investment Management is opposing the sale of Swedish Match AB to Philip Morris for $16 billion.

According to sources familiar with the matter, Elliott Investment Management is building a stake in Swedish Match AB. Swedish Match AB is a smokeless tobacco company that has agreed to be sold to Philip Morris International for $16 billion.


According to insiders, a US activist investor is reportedly planning to oppose the current terms of the deal and has requested that their identity remains confidential. Swedish Match had previously agreed in May to be acquired by PhiMo International.


A representative of Elliott declined to comment. Representatives from Swedish Match and Fempro International were unable to be reached for immediate comment.


On Friday, the stock price of Swedish Match increased by 1.7%, causing the company's market value to reach 161.3 billion kronor ($15.2 billion).


This transaction is subject to many conditions, including Fimo International acquiring over 90% of Swedish Match's shares through a bid, unless it chooses to waive this condition. At the end of last year, AstraZeneca Plc withheld 8% of Biovitrum AB's shares from its acquisition by Advent International and Singapore's GIC Pte, effectively preventing the purchase for $7.6 billion, highlighting the impact of opposition from major shareholders.


Freeze shares.


According to analyst Mads Rosendal of Danske Bank A/S, it is unlikely that Elliott will be able to acquire a large enough stake in Swedish Match to single-handedly block the deal.


In a research report on Friday, he wrote, "Even if they successfully block this transaction, it may not be detrimental to Swedish Match's profitability.


According to Rosendal, if the original agreement is reached, Swedish Match would be better off from a financial and credit rating perspective, but would suffer damage in terms of environmental, social, and governance considerations.


The Swedish Match deal is one of the biggest transactions this year, pushing FeiMo International into the fiercely competitive market for oral nicotine products, many of which are very different from traditional chewing tobacco.


Swedish Match is a prominent manufacturer of snuff, a tobacco product that users place between their upper lip and gum. It is popular in Sweden but banned in other parts of Europe. The company also produces nicotine pouches known as ZYN.


In recent years, Elliot Management Corporation, run by billionaire Paul Singer, has been concerned with the changes taking place in some of the world's largest and most well-known companies, including Twitter, Canadian National Railway and American multinational conglomerate AT&T. In Europe, the company last year drove the transformation of pharmaceutical firm GSK Plc and energy company SSE Plc.


I'm sorry, as an AI language model, I already operate and communicate in standard journalistic English. If you have a specific sentence or text that you want me to translate, please provide it.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
Brazil’s Teen E-Cigarette Experimentation Rate Rises to 29.6% Over Five Years
Brazil’s Teen E-Cigarette Experimentation Rate Rises to 29.6% Over Five Years
Brazil’s National School Health Survey (PeNSE) 2024 found that e-cigarette experimentation among students aged 13 to 17 rose from 16.8% in 2019 to 29.6% in 2024, while use in the previous 30 days increased from 8.6% to 26.3%. Over the same period, conventional cigarette experimentation fell from 22.6% to 18.5%, and hookah use declined from 26.9% to 16.4%.
Mar.26 by 2FIRSTS.ai
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new Argentine framework for tobacco and nicotine marks a shift from prohibition towards registration, traceability, and health surveillance. Juan Facundo Teme told 2Firsts that adult consumers and some of the commercial sector are cautiously optimistic, although concerns remain about flavors, registration costs, and market access.
May.11
Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications
Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications
A three-judge panel of the U.S. Court of Appeals for the Fifth Circuit heard oral arguments on Tuesday in a case brought by seven small vape-liquid companies challenging the Food and Drug Administration’s denial of marketing authorization for their flavored electronic nicotine products.
Apr.30 by 2FIRSTS.ai
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
According to a complaint filed on March 17 in the U.S. District Court for the Northern District of Texas, Fontem US, LLC and Texas retailer OM Investment, LLC sued the Food and Drug Administration and the Department of Health and Human Services over FDA’s refusal-to-file decision for certain Zone nicotine pouch PMTAs.
Mar.19 by 2FIRSTS.ai